Category filter:

Acronym	Definition
DLI	Digital Library of India (Indian Institute of Science)
DLI	Defense Language Institute
DLI	Division of Labor and Industry (Maryland)
DLI	Daily Light Integral (photosynthetic light measurement)
DLI	Data Liberation Initiative (Canada)
DLI	Donor Lymphocyte Infusion
DLI	Data Manipulation Language of Ims
DLI	Distributor-Less Ignition
DLI	Digital Libraries Initiative (Library of Congress, National Science Foundation)
DLI	Dalat (airport code, Vietnam)
DLI	Durham Light Infantry (Regiment of the British Army)
DLI	Data Link Interface
DLI	Drama League of Ireland
DLI	Diversity Leadership Institute
DLI	Division Légère d'Intervention (French: Light Intervention Division)
DLI	Department of Labor and Industries (US States)
DLI	Department of Land Information (Western Australia)
DLI	Deep Listening Institute (Kingston, NY)
DLI	Danielle Lesage Intérim (French employment agency)
DLI	Distributorless Ignition
DLI	Distance Learning, Inc. (software)
DLI	Direct Liquid Injection
DLI	Dansk Lægemiddel Information (Danish: Danish Medicine Information; Copenhagen, Denmark)
DLI	Dispositifs de Libération d'Insuline (French: Devices for Insulin Release)
DLI	Distance Learning International (Richmond, VA)
DLI	Development Leadership Initiative (USAID)
DLI	Dai-Ichi Life International (various locations)
DLI	Development Through Local Integration (humanitarian aid)
DLI	Dolby Laboratories Inc.
DLI	Drycleaning and Laundry Institute (Laurel, MD)
DLI	Date Last Insured
DLI	Device Layer Interface
DLI	Disneyland Info
DLI	Deck-Launched Interceptor
DLI	Distinct Location Identification
DLI	Department of Licenses and Inspections (Philadelphia)

References in periodicals archive

Chen et al., "Natural killer cell-enriched donor lymphocyte infusions from a 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation," Biology of Blood and Marrow Transplantation, vol.

High-Risk Leukemia: Past, Present, and Future Role of NK Cells

Between May and August of 2010, donor lymphocyte infusions (DLI) were performed twice, with CD3 cells doses of 1 x [10.sup.7]/kg and 1 x [10.sup.8]/kg, respectively, with no response.

Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia

Schattenberg et al., "Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion," Bone Marrow Transplantation, vol.

Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment

Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major.

Mixed chimerism following hematopoietic stem cell transplantation in pediatric thalassemia major patients: a single center experience/ Pediatrik talasemi major hastalarinda hematopoetik kok hucre nakli sonrasi karisik tip kimerizm-tek merkez sonuclari

Donor lymphocyte infusions (DLIs), which are based on the effects of graft-vs-leukemia (20), have been used to treat post-BMT leukemia relapse and have been shown to have a potent antileukemic effect that can lead to hematologic/ molecular remission in 75-80% of CML patients who relapse after BMT (23).

Monitoring of hematopoietic chimerism by short tandem repeats, and the effect of CD selection on its sensitivity

Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A retrospective analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Abbreviations [alpha][beta]: Alpha beta BM: Bone marrow CB: Cord blood CBU: Cord blood units CD: Cluster of differentiation CMV: Cytomegalovirus DLI: Donor lymphocyte infusions EBV: Epstein Barr virus GF: Graft failure GVHD: Graft versus host disease GVL: Graft versus leukemia [gamma][delta]: Gamma delta G-CSF: Granulocyte colony stimulating factor HLA: Human leukocyte antigen HSCT: Allogeneic hematopoietic stem cell transplantation HSC: Hematopoietic stem cells MHC: Major histocompatibility complex MUD: Matched unrelated donor NK: Natural killer PBSC: Peripheral blood stem cells UCB: Umbilical cord blood TCR: T-cell receptor PLT: Platelets WBC: White blood cells.

Alpha/beta T-Cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors

[74] investigated long-term IR after RIC based haplo-SCT with TCD, which followed by preemptive donor lymphocyte infusions (DLI).

Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation

Since the survival was very poor, all possible treatment options like second transplantation and donor lymphocyte infusions should be tried.

Extramedullary Relapse in a CML Patient after Allogeneic Stem Cell Transplantation

Cytotoxic lymphocytes (CTLs), donor lymphocyte infusions (TILs) and tumor infiltrating lymphocytes (TILs) complement the spectrum of the report.

TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of Technologies Opens Business Opportunities Beyond CD19 CARTs

Several small studies have recently introduced simultaneous application of 5-Aza combined with donor lymphocyte infusions in AML patients [9-12].

5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity

Unmanipulated donor lymphocyte infusions (DLI) containing virus-specific T cells have been trialled in patients with EBV infections which resulted in clearance of infection but increased the risk of GHVD due to high frequency of alloreactive cells [52].

Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation